Table 2.
Crude incidence rates and mortality rates among N=1,312 participants with 2,730 person-years of follow-up
| Group | Incident HIV | Death |
|---|---|---|
| Rate per 1,000py (95%CI) | Rate per 1,000py (95%CI) | |
| All | 5·5 (2·7–8·3) | 3·3 (1·5–6·3) |
| Cohort mode | ||
| Digital | 1·6 (0·2–5·8) | 0·8 (0·0–4·5) |
| Site-based | 8·7 (4·0–13·5) | 5·4 (2·3–10·6) |
| Race & ethnicity 1 | ||
| White | 1·6 (0·3–4·7) | 3·2 (1·2–7·0) |
| Black | 19·3 (8·4–30·2) | 4·8 (1·0–14·1) |
| Hispanic/Latinx ethnicity | 9·9 (3·2–23·1) | 9·9 (3·2–23·1) |
| Geographic region | ||
| North | 3·0 (0·8–7·7) | 0·0 (0·0–2·8) |
| Mid-Atlantic | 4·8 (1·0–14·1) | 4·8 (1·0–14·1) |
| South | 10·3 (4·5–20·3) | 7·7 (2·8–16·8) |
| Age category | ||
| 18–24 | 8·5 (3·4–17·5) | 3·6 (0·8–10·6) |
| >=25 | 4·2 (1·8–8·3) | 3·2 (1·2–6·9) |
| PrEP indicated at baseline 2 | ||
| No | 0·7 (0·0–3·8) | |
| Yes | 11·2 (5·3–17·0) |
Notes:
1
Categories are not mutually exclusive, as participants may report multiple race or ethnic identities;
2
PrEP indication based on an adapted version of CDC criteria for transgender women22